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Impaired Development of Th2 Cells
in IL-13-Deficient Mice
production of immunoglobulin E (IgE)and the accumula-
tion of eosinophils, both of which are highly detrimental
in asthma and allergic reactions (Bousquet et al., 1990;
Grahame J. McKenzie,* Claire L. Emson,*
Sarah E. Bell,² Shannon Anderson,*
Padraic Fallon,§ Gerard Zurawski,³
Sutton and Gould, 1993). It is unclear how such Th cellRichard Murray,³ Richard Grencis,‖
commitment occurs, but factors including the route ofand Andrew N. J. McKenzie*#
antigenic challenge, the type of antigen-presenting cell,*MRC Laboratory of Molecular Biology
the cytokine milieu at the site of challenge, and the doseHills Road
of the antigen are all believed to influence the skewingCambridge CB2 2QH
of T helper cell phenotypes.United Kingdom
Recent studies have identified multiple pathways that²Wellcome Trust Immunology Unit
appear to be involved in the initiation of Th2 cell re-University of Cambridge
sponses. These include the signals induced by TCRCambridge CB2 2SP
ligation, IL-4, the modulation of IL-12Rb2, and ligationUnited Kingdom
of CD4 and CD28 (reviewed by O'Garra, 1998). IL-4-³DNAX Research Institute
mediated signals are of primary importance in potentiat-901 California Avenue
ing a Th2 cell response, with addition of IL-4 to in vitroPalo Alto, California 94304
T cell cultures resulting in the induction of a Th2 cell§Department of Pathology
phenotype (Le Gros et al., 1990). Furthermore, deletionUniversity of Cambridge
of the IL-4 gene in mice results in a diminution of Th2-Cambridge CB2 1QP
like responses (Kopf et al., 1993), though residual Th2-United Kingdom
like cell lineages can still be isolated from these animals,‖School of Biological Sciences
indicating that IL-4-independent mechanisms for Th2-University of Manchester
like cell development exist (Kopf et al., 1993: Brewer etManchester, M13 9PT
al., 1996). In addition, under certain stimulations, suchUnited Kingdom
as infection with malaria parasites or MAIDS, these IL-
4-deficient mice can still produce IgE (Van der Weld et
al., 1994; Morawetz et al., 1996). Significantly, recentSummary
evidence has shown that IL-4 can down-regulate the
expression of IL-12Rb2 on Th2 cells, thus making themWe report that Th2 cell cultures generated using T
insensitive to IL-12 signals that would normally invoke
cells or splenocytes from IL-13-deficient mice produce
a Th1 cell response (Szabo et al., 1997).
significantly reduced levels of IL-4, IL-5, and IL-10
IL-13 is a recently described cytokine (Brown et al.,
compared with wild-type. In contrast, IL-4 and IL-5
1989; McKenzie et al., 1993a) encoded by a gene map-
production by mast cells stimulated in vitro with PMA, ping to a cytokine gene cluster on mouse chromosome
ionomycin, or IgE cross-linking are unaffected. In vitro 11 and human chromosome 5 that also includes the
Th2 cell differentiation cannot be rescued by the addi- genes encoding IL-3, IL-4, IL-5, and granulocyte-macro-
tion of exogenous factors, but in vivo antigen chal- phage-colony stimulating factor (GM-CSF) (McKenzie et
lenge and administration of IL-13can increase Th2-like al., 1993b). IL-13 is produced principally by activated T
cytokine responses as can infection with the parasitic cells, and though expression is primarily associated with
nematode Nippostrongylus brasiliensis. IL-13-deficient the Th2 lineage, human Th1 and Th0 cell clones may
mice also have lower basal levels of serum IgE and also make IL-13 (Zurawski and de Vries, 1994). Using in
biased antigen-specific immunoglobulin responses. vitro culture systems, the biological activities of IL-4 and
Thus, IL-13 is an important regulator of Th2 commit- IL-13 have been found tooverlap, inducing immunoglob-
ment and may therefore play a central role in atopy ulin isotype switching to IgE in human B cells (Punnonen
and infectious diseases. et al., 1993) and suppressing inflammatory cytokine pro-
duction in both human and mouse systems (de Waal
Introduction Malefyt et al., 1993; Doherty et al., 1993).
The relatedness of the responses induced by IL-13
The identification of a functional polarization of mouse and IL-4 has been elucidated by studies showing that
CD41 T helper (Th) cell clones based on their cytokine both of these cytokines can interact and cross-compete
secretion profiles has provided a molecular insight into for IL-4 receptor a (IL-4Ra) (Zurawski et al., 1993; Smerz-
the regulation of immune responses (Mosmann et al., Bertling and Duschl, 1995). However, the exact constitu-
1986; Mosmann and Coffman, 1989). Th1 cells secreting tion of the receptor complexes engaging the individual
IL-2, interferon-g (IFNg) and lymphotoxin-b (LTb) repre- cytokines is poorly understood, though it is apparent
sent a T cell subset important in enhancing cellular im- that IL-13 has its own primary binding chains (IL-13Ra1
mune responses, while Th2 cells, characterized by their and IL-13Ra2), to which IL-4 does not bind (Zurawski
secretion of IL-4, IL-5, IL-6, IL-9, IL-10, and IL-13, evoke et al., 1995; Aman et al., 1996; Caput et al., 1996; Hilton
et al., 1996; Gauchat et al., 1997; Miloux et al., 1997).
Although IL-4 has been reported to interact with IL-2Rgc# To whom correspondence should be addressed (e-mail: anm@
mrc-lmb.cam.ac.uk). chain (Kondo et al., 1993), no such interaction has been
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shown for IL-13 (He and Malek, 1995; Lin et al., 1995).
Thus, while a number of intracellular signaling pathways
are common to IL-13 and IL-4, such as Janus kinase 1
(JAK1) and signal transducer and activator of transcrip-
tion 6 (Stat6) (Lin et al., 1995), others may be more
specific. Significantly, recent datagenerated using para-
sitic nematode infections of IL-42/2, Stat62/2, IL-4Ra2/2,
and IL-132/2 animals have indicated that IL-13 plays an
essential role in Th2 cell-mediated expulsion of these
worms (Bancroft et al., 1998; McKenzie et al., 1998;
Urban et al., 1998) and indicate that in some instances
Stat6 signaling is IL-13-dependent. In addition, studies
using IL-42/2 and IL-4Ra2/2 to study the Th2 cell pheno-
type induced by Schistosoma mansoni implicate IL-13
in the process of granuloma formation (Jankovic et al.,
1998). Thus, IL-13 plays a critical role in thedevelopment
of a number of Th2 cell-mediated responses in vivo.
Interestingly, treatment of mice with a polyclonal anti-
body raised against mIL-13 resulted in a decrease in
the levels of IL-4 being made by antigen-specific T cells
in response to immunization (Bost et al., 1996), sug-
gesting that inhibiting IL-13 function results in impaired Figure 1. Disruption of the IL-13 Gene by Gene Targeting
IL-4 expression. Herein, we present data derived from (A) The structure of the IL-13 locus, the targeting vector, and the
the study of IL-132/2 mice that demonstrate animportant predicted homologous recombination event are shown. A replace-
ment targeting vector containing 6 kb and 1.5 kb of 59 and 39 homol-regulatory role for IL-13 in the development of Th2 cell
ogy, flanking the neomycin resistance gene, was constructed.lineages. Using a combination of in vitro assays and in
(B) Southern blot analysis of F2 tail DNA. BglII-digested DNAs werevivo stimulations, we have found that CD41 helper T
hybridized with the 39 flanking probe (probe A). The endogenouscells from IL-132/2 mice display a significant impairment
and targeted alleles are 6.0 kb and 7.2 kb, respectively.
in their ability to develop a Th2 cell lineage following
in vitro Th cell differentiation. We found that antigen-
specific responses are less overtly affected by the loss splenocytes was used initially to determine the levels
of IL-13 expression and that infection with the Th2-phe- of IL-4, IL-5, IL-10, and IFN-g being secreted 24±96 hr
notype-inducing gastrointestinal nematode Nippostron- poststimulation. Profoundly reduced levels of IL-5 and
gylus brasiliensis was able to overcome the impairment.
moderately less IL-4 were produced by cells from the
Additionally, IL-132/2 mice have significantly reduced
IL-132/2 mice, and IL-5 levels remained low even when
IgE levels. These results suggest that IL-13 performs
cells were costimulated with excess IL-4 for 96 hr; no
a central role in the development of certain immune
significant differences were found in IFNg production
responses and that its interrelatedness with IL-4 is
(data not shown). Similar responses were observed withcomplex.
purified CD41 T cells stimulated with mitogen (data not
shown).Results
As IL-5 and IL-4 are known to be produced predomi-
nantly by Th2 cells, we assessed the consequences ofGeneration of IL-13-Deficient Mice
IL-13 disruption on T helper cell differentiation. PurifiedTargeted disruption of the mouse IL-13 gene was per-
CD41 T cell cultures were stimulated for 5 days to pro-formed by inserting the neomycin resistance (neor) cas-
mote either Th1 or Th2 differentiation. As expected, re-sette into exon 3 using a replacement targeting con-
stimulationof cell culturessupporting Th2differentiationstruct (Figure 1A). Correctly targeted clones were used
from wild-type mice resulted in the secretion of IL-4,to generate chimaeric mice that were bred with 129/J
IL-5, and IL-10 (Figure 2A). In contrast, equivalent cellmice and transmitted the disrupted allele through the
cultures from IL-132/2 mice produced dramatically re-germline. Interbreeding of heterozygous (IL-131/2) mice
duced levels of IL-4 and IL-5 and a 2-fold reduction ingave rise to homozygous gene targeted mice (IL-132/2,
IL-10, despite the inclusion of exogenous IL-4 duringFigure 1B). These animals were viable and of normal
the 5-day culture period (Figure 2A). We also noted thatappearance and behavior. IL-13-specific ELISA failed
Th2 cells from wild-type mice made significant levels ofto detect IL-13 protein in supernatants conditioned by
IL-13 and that wild-type Th1 cells also produced moder-activated Th2 cells from the IL-132/2 mice (Figure 2A).
ate amounts of IL-13. As expected, cells from the IL-No mRNA transcripts encoding IL-13 could be detected
132/2 animals failed to produce IL-13 (Figure 2A). Inter-by RT-PCR using RNA isolated from in vitro culture of
estingly, inclusion of IL-13 in the T cell differentiationConcanavalin A (Con A)-stimulated splenocytes from
assays failed to reverse the observed phenotype (Figurethe IL-132/2 mice, though their wild-type littermates dis-
2A). Following T cell restimulation, levels of IFNg produc-played normal expression (data not shown).
tion were approximately 2-foldgreater from cellsderived
from IL-132/2 animals compared to levels from wild-typeCD41 T Lymphocytes and Splenocytes Display
cells (Figure 2A).an Impairment in Th2 Differentiation
To determine whether the inclusion of additional cellWe used in vitro assays to assess the result of IL-13
deletion on cytokine production. Con A stimulation of populations into the in vitro Th2 cultures could rescue
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reverse the impairment in cytokine production from IL-
132/2 Th2 cell cultures.
The differences in the cytokine profiles were not due
to variation in overall cell proliferation, since growth re-
sponses to Con A, IL-2, or IL-4 were equivalent in IL-
132/2 and wild-type mice (data not shown). Indeed, the
up-regulation of activation markers and the proliferation
of splenocytes, lymph node cells, and purified T cells
in response to IL-4, either alone or in combination with
coactivators such as lipopolysaccharide (LPS),anti-IgM,
and anti-CD40 were equivalent inboth IL-132/2 and wild-
type mice (data not shown).
Antigen Stimulation and Parasitic Infection
Induce Production of IL-4 and IL-5
We analyzed theCD41 T cell populations that developed
during in vitro differentiation using intracellular cytokine
analysis. This demonstrated that populations of IL-4-
and IL-5-producing cells were still present but that there
was a significant reduction in the number of IL-5- and
IL-4-producing cells in the Th2 cell cultures derived from
the IL-13-deficient mice, as compared to those from
wild-type cultures (data not shown).
The development of cells capable of producing IL-4
and IL-5 was further illustrated when IL-13-deficient
mice were challenged with a complex antigen. We as-
sessed the antigen-specific cytokine response gener-
ated against schistosome eggs, an antigen that has
been shown to induce Th2 cell responses (Pearce et al.,
Figure 2. Cytokine Production Following In Vitro Th Cell Differenti- 1991). Following immunization, the levels of IL-5 pro-
ation duced by lymph node cell cultures from both the IL-
(A) CD41 T cells purified from pooled spleens from three wild-type 132/2 and wild-type animals were similar, varying by
or three IL-132/2 mice were stimulated under Th1 or Th2 culture
only 2-fold, and the levels of IL-4 were only approxi-conditions (or Th2 conditions with the addition of 100 ng/ml IL-13)
mately 3-fold lower in the IL-13-deficient mice as com-for 5 days, washed, and restimulated on anti-CD3 antibody coated
pared to the wild-types (Figure 3A). However, if theplates for 24 hr. Supernatants were analyzed by ELISA. Data are
representative of four repeat experiments. lymph node cells from the immunized animals were cul-
(B) Splenocytes were stimulated under Th1 or Th2 culture conditions tured using in vitro Th2cell differentiation conditions and
for 5 days, washed, and restimulated on anti-CD3 antibody coated stimulated with anti-CD3 and anti-CD28, then a more
plates for 24 hr. Supernatants were analyzed by ELISA. Data are
severe impairment of IL-5 and IL-4 production was ob-representative of five repeat experiments.
served (Figure 3B). Thus, the antigen-driven in vivo T
cell response was only moderately influenced by the
absence of IL-13, in contrast with the profound defect
seen in the cell population normally responsive duringthe observed phenotype, we set up Th2 cultures with
total spleen cell populations from IL-132/2 and wild- in vitro Th2 cell differentiation.
We next assessed the affect of infecting IL-132/2 micetype mice. These total splenocyte assays also failed to
overcome the impairment in the in vitro differentiation with the intestinal parasitic nematode N. brasiliensis on
the development of Th2 cell populations. Lymph nodecapacity of Th2 cell lineages in IL-132/2 cell cultures,
with significant reductions in IL-4, IL-5, and IL-10 cells were prepared from wild-type and IL-132/2 animals
at 6 and 10 days postinfection with N. brasiliensis. Theseproduction even in the presence of exogenous IL-4 (Fig-
ure 2B). cells were cultured under conditions supporting Th2 cell
differentiation, and supernatants were assessed for theThe pattern of Th2 cytokine expression remained con-
sistently lower in cells from the IL-132/2 mice irrespec- presence of Th2 cell cytokines. As shown in Figure 3C,
the preinfection IL-132/2 lymph node cultures (day 0)tive of whether anti-CD3 or Con A stimulation was used
or if cultures included IL-4 or IL-13 (data not shown). display a significant impairment in IL-4, IL-5, and IL-10
expression, similar to that observed for purified CD41IL-13, in the absence of IL-4, also failed to reverse the
observed cytokine phenotype in the T cell differentiation T cells and splenocytes using equivalent culture condi-
tions. However, following infection, isolated lymph nodeassays (data not shown). Furthermore, stimulation of
differentiated CD41 T cells with phorbol myristate ace- cells from IL-132/2 mice cultured in Th2 cell differentia-
tion conditions nowgenerate typical cytokine responsestate (PMA) and ionomycin, which normally induce signifi-
cant levels of cytokine expression from T cells, yielded at day 6 postinfection (Figure 3C). These results indicate
that antigenic challenge in the form of a sustained para-similar cytokine profiles to those elicited by anti-CD3
and anti-CD28 (data not shown), indicating that a range site infection can overcome the deficit in the signals
required to develop Th2 cell responses.of reported cytokine-inducing stimuli were unable to
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Figure 4. Th2 Cytokine Production Following Removal of the Neo-
mycin Selection Cassette Using cre-Mediated loxP Recombination
(A) The structure of the IL-13 locus, the targeting vector, and the
predicted homologous recombination event before and after exci-
Figure 3. Cytokine Production in Response to Antigen Immuniza-
sion of the neomycin cassette are shown (loxP sites indicated by
tion or Parasite Infection
broad arrows).
(A) Mesenteric lymph node cells, isolated from schistosome egg (B) Southern blot analysis of ES cell genomic DNA following cre-
challenged animals, were cultured with soluble egg antigen (SEA) mediated recombination. BamHI-digested DNAs were hybridized
for 5 days before supernatants were analyzed for IL-4 and IL-5 with the IL-13 cDNA probe. The endogenous allele and targeted
production by ELISA. Representative data from three repeat experi- alleles are 6.0 kb and 4.8 kb, respectively. The neomycin excised
ments with five animals per group. allele is 3.2 kb (1/2 creed).
(B) Mesenteric lymph node cells, isolated from schistosome egg- (C) Mesenteric lymph node cells from wild-type and IL-132/2 creed
challenged animals, were cultured using Th2 differentiation condi- were stimulated under Th2 culture conditions for 5 days, washed,
tions. Representative data from three repeat experiments with five and restimulated on anti-CD3 antibody-coated plates for 24 hr. Su-
animals per group. pernatants were analyzed by ELISA. Data are representative of two
(C) Mesenteric lymph node cells were prepared from uninfected repeat experiments with three mice per group.
animals (day 0) or animals 6 days and 10 days postinfection with
N. brasiliensis. Cells were stimulated under Th2 culture conditions
for 5 days, washed, and restimulated on anti-CD3 antibody coated Lymph node cells from these animalsand wild-type mice
plates for 24 hr. Supernatants were analyzed by ELISA. Data are were cultured under conditions supporting Th2 cell dif-
representative of two repeat experiments consisting of cohorts of
ferentiation, and following restimulation an impairmentfive mice at each time point.
of IL-4 and IL-5 production was still evident in cultures
from the IL-132/2 creed mice (Figure 4C). These results
indicate that even with the removal of the exogenous
PGK promoter-driven neomycin gene in vitro Th2 cellRemoval of the PGK/Neomycin Resistance Cassette
Does Not Reverse the Impairment in In Vitro development is impaired and that promoter interference
is not responsible for the observed phenotype.Th Cell Differentiation
Since it was possible that the impairment in T helper
cell responses might be due to the presence of the Mast Cell Cytokine Production Is Unaffected
by IL-13 Deletionexogenous phosphoglycerate kinase (PGK) promoter
used to drive the expression of the neomycin resistance To determine whether there was a global change in the
secretion of IL-4 and IL-5, we isolated mast cell popula-gene, we utilized cre-mediated loxP recombination to
remove both of these elements from targeted ES cells tions from spleen and bone marrow and assessed their
ability to produce these cytokines. Significantly, IL-132/2(Figures 4A and 4B). These cells were then used to
generate homozygous IL-132/2 mice that no longer con- and wild-type mast cells secreted equivalent levels of
IL-4 and IL-5 upon stimulation with PMA and ionomycin,tained the neomycin selectable marker or its promoter.
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Figure 6. Cytokine Production Following In Vivo Administration
of IL-13Figure 5. Mast Cell Cytokine Production
(A) Mesenteric lymph node cells from wild-type animals immunized(A) Mast cells were stimulated with PMA and ionomycin and super-
with schistosome eggs and IL-13, or denatured IL-13 (con), werenatants were sampled after 24 hr. Cytokine levels were analyzed by
cultured with soluble egg antigen for 5 days. Representative dataELISA. Representative data from three repeat experiments with cells
from two repeat experiments with five animals in each group. Super-prepared from three mice.
natants were assayed for cytokine concentration using ELISA.(B) RT-PCR analysis of spleen-derived mast cells stimulated with
(B) Mesenteric lymph node cells, derived from N. brasiliensis±IgE and specific antigen, PMA, and calcium ionophore A23187.
infected wild-type animals, IL-132/2 animals, or IL-132/2 animals
treated with rmIL-13, were stimulated for 24 hr with Con A. Superna-
tants were analyzed for the presence of IL-5 and IL-4 by ELISA.
indicating that this cell population is unaffected by IL-13 Data represent triplicate cultures from five animals per group.
deletion (Figure 5A); wild-type mast cells also secreted
significant levels of IL-13 (Figure 5A). Furthermore, RT-
(data not shown). Thus, animals were coadministered
PCR analysis of IL-4 and IL-5 mRNA produced by IL-
with rmIL-13 and schistosome eggs followed by two
132/2 and wild-type mast cells, using samples in which
further doses of rmIL-13 intraperitoneally over a 10-day
competitive PCR was used to determine relative HPRT
period. Mice were then sacrificed and mesenteric lymph
levels, indicated identical stimulation-specific transcrip- node cells isolated and cultured with antigen. Lymph
tional activation in the presence of PMA, ionomycin, or node cells derived from IL-13-treated wild-type animals
DNP cross-linked anti-DNP IgE monoclonal antibody produced elevated levels of antigen-induced IL-5 when
(Figure 5B). These data demonstrate that disruption of cultured in the presence of schistosome soluble egg
the IL-13 gene does not affect the development of mast antigen (Figure 6A). No such increase was observed in
cells or their ability to express Th2-like cytokines and cultures from mice inoculated with denatured IL-13. We
indicate that the developmental deficit in Th2-like cyto- were also unable to show an increase in IL-5 produced
kine production is T cell±specific. Furthermore, since by cultures of IL-132/2 cells (data not shown). Further-
the IL-132/2 mast cell populations are fully responsive more, there was no reproducible change in the levels
to a range of stimuli, including PMA and ionomycin, of IL-4 from either set of animals (Figure 6A). Thus, ad-
which were unable to elicit IL-4 and IL-5 production ministration of IL-13 with antigen can modulate the ex-
from the T cell population in IL-132/2 mice, these results pression of IL-5 in vivo.
support the finding that insertion of the neomycin gene In addition to the results using a protein immunization
into this locus has not affected the regulation of the IL-4 strategy, we found that in vivo rmIL-13 treatment of IL-
and IL-5 genes. 132/2 animals infected with N. brasiliensis induced an
increase in the levels of IL-4 and IL-5 secreted following
Administration of Recombinant IL-13 and Antigen 24 hr Con A stimulation of mesenteric lymph node cells
In Vivo Increases Cytokine Production (data not shown) or CD41 purified T cells relative to
Since addition of IL-13 to in vitro cultures from wild- levels from mock treated animals (Figure 6B). Thus, in
type or IL-13-deficient animals failed to influence Th2 combination with antigenic challenge, administration of
differentiation, we attempted to mediate an in vivo effect IL-13 can influence cytokine secretion patterns.
on cytokine production using recombinant mouse IL-13
(rmIL-13) to inoculate both IL-13-deficient and wild-type Reduced Serum IgE Levels and Modulated B Cell
mice. The administration of rmIL-13 in the absence of Expression of CD23 in the Absence of IL-13
antigen failed to mediate any effect on subsequent in No significant differences were detected in the number
or composition of cells from spleen, thymus, lymphvitro Th2 cell differentiation in wild-type or IL-132/2 mice
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Figure 7. Serum Immunoglobulin Levels from
Naive and Immunized Animals
(A) Total serum concentration of immuno-
globulin isotypes from naive wild-type and IL-
132/2 mice. Representative data from three
repeat experiments. (B) Serum IgE levels from
mice immunized with ovalbumin/alum. Rep-
resentative data from two repeat experi-
ments. Closed circle, wild-type; open circle,
IL-132/2; plus, mean.
(C) Serum IgE levels detected at day 10 post-
infection of mice with N. brasiliensis (data
represent the mean (6 SD) in groups of five
mice). Shaded columns are wild-type, open
columns are IL-132/2.
(D) Serum ovalbumin-specific immunoglobu-
lin isotype responses to ovalbumin/alum fol-
lowing immunization over a 40-day period.
Cohorts of five animals were analyzed.
node, and bone marrow from the wild-type and IL-132/2 Discussion
mice when we examined the cell surface expression of
a panel of immunoregulatory molecules including CD4, IL-13-deficient mice have highlighted an important regu-
CD8, CD3e, CD69, CD25, sIgM, CD28, CD90.2, Mac-3, latory role for IL-13 in the development of T helper cell
CD80, CD86, c-Kit receptor, Gr-1, TER-119, CD54, F4/ responses and have also raised the issue of a direct
80, B220, CD11b, and IL-4Ra (data not shown). How- role for IL-13 in the control of IgE production in the
ever, we detected significantly reduced levels of CD23 mouse system. Using a number of in vitro and in vivo
expression (the low-affinity receptor for IgE) on B2201 based assays, we have shown that deletion of the IL-
splenocytes from the IL-132/2 mice relative to those 13 gene results in attenuated development of certain T
from the wild-type animals (data not shown). Culture of cell lineages with a consequent reduction of Th2 cell
splenocytes from either wild-type or IL132/2 animals, cytokines. These results are consistent with a study
in the presence of anti-CD40 antibody, induced similar in which anti-IL-13 polyclonal antibodies were used to
levels of CD23 expression on both populations (data not block IL-13 function, resulting in a significant reduction
shown), indicating that the intrinsic ability to up-regulate in T cell±derived IL-4 (Bost et al., 1996), and a recent
expression of CD23 was not impaired in the IL-132/2 report in which IL-4Ra2/2 mice exhibited a more severe
cells. impairment in Th2 development than that observed in
Measurement of serum immunoglobulins in nonimmu- IL-42/2 mice (Barner et al., 1998). The molecular mecha-
nized IL-132/2 mice revealed a 5- to 20-fold decrease nism(s) by which IL-13 mediates its effects are unclear,
in total serum IgE levels compared to wild-type animals, and it remains possible that IL-13 may act indirectly
while the levels of other immunoglobulin isotypes were or directly on T cell populations. Intracellular cytokine
not significantly different (Figure 7A). Upon immuniza- analysis indicated that significantly fewer IL-132/2 T cells
tion with ovalbumin/alum, increased production of total are producing IL-4 or IL-5 and that this population does
serum IgE was detected in both the wild-type and the
not expand as is seen in the wild-type cultures. These
IL-13-deficient animals, although the levels seen in the
data correlate well with the cytokine ELISA data and
IL-132/2 mice did not reach those observed in the wild-
may suggest that cytokine production on an individual
type controls (Figure 7B). Total serum levels of IgE were
cell basis is comparable between wild-type and IL-132/2also found to increase in the IL-132/2 mice upon infection
mice and that the defect may lie in the generation ofwith N. brasiliensis (Figure 7C).
these cells.Since total IgE expression was perturbed in naive IL-
To date, the addition of exogenous IL-13 to the in vitro132/2 mice, their ability to generate a specific antibody
differentiation assays has failed to reverse the cytokineresponse to a protein antigen was assessed. Wild-type
secretion profile observed in T cells isolated from IL-and IL-132/2 mice were immunized over a 40-day period
13-deficient mice. Thus, commitment or expansion of awith ovalbumin (OVA) complexed to alum, and serum
responsive cell type apparently fails to occur in the IL-samples isolated pre- and postimmunization were ana-
13-deficient mice and cannot be redirected in culture,lyzed for OVA-specific immunoglobulin isotype content
possibly due to changes in receptor expression and/orby ELISA. The total antigen-specific immunoglobulin re-
intracellular signaling pathways during development orsponse in wild-type and IL-132/2 mice was comparable,
upon derivation of these cells. Since exogenous IL-4as was the OVA-specific IgG1 response (Figure 7D).
also failed to reverse the phenotype of the cells fromHowever, while IL-132/2 mice generated small but signif-
the IL-132/2 mice, our results suggest that IL-13 actsicant concentrations of OVA-specific IgG2b antibodies
upstream of IL-4 in this process. The IL-132/2 phenotypeand an elevated OVA-specific IgM response, these iso-
types were undetectable in wild-type (Figure 7D). contrasts with that observed in IL-42/2 mice in which
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CD41 T cells produce reduced levels of IL-5 and IL- It is evident that administration of antigen can over-
come at least some of the impairment in cytokine pro-10 but regain wild-type levels of these cytokines when
exogenous IL-4 is addedto in vitro differentiation assays duction observed in IL-132/2 mice and that concurrent
administration of recombinant IL-13 can enhance Th2(Kopf et al., 1993; A.N.J.M., unpublished data).
As IL-13 is a potent modulator of macrophage function cytokine expression still further. It is also apparent that
infection of IL-132/2 animals with the gastrointestinal(de Waal Malefyt et al., 1993; Doherty et al., 1993; Mu-
chamuel et al., 1997; Nicoletti et al., 1997), it is possible nematode worm, N. brasiliensis, circumvents the impair-
ment in Th2 bias seen in vitro. It is noteworthy that atthat in the absence of IL-13 macrophages fail to regulate
correctly their expression of cytokines such as IL-6 or 10 days postinfection, 24 hr Con A stimulation of lymph
node cells results in lower levels of IL-4 production byIL-12, which have been reported to promote T cell differ-
entiation (Manetti et al., 1993; RincoÂ n et al., 1997). IL- the IL-132/2 cells as compared to wild-type cells (Mc-
Kenzie et al., 1998), but that in vitro Th2 culture results12 is a potent inducer of Th1 cell differentiation (Hsieh
et al., 1993) and thus deregulated IL-12 production may in a marked increase in IL-4 production by IL-132/2 cells
as compared to wild-type cells (Figure 3C), probably asinfluence the subsequent differentiation potential of T
cell lineages in the IL-132/2 animals. Indeed, we did a result of the duration and persistence of the nematode
infection. It is possible that infection may enhance otherobserve that activated macrophages from IL-132/2 mice
produced elevated levels of IL-12 (G.J.M., unpublished regulatory pathways such as IL-10, thereby suppressing
IL-12 and overcoming the deficit in IL-13. Alternatively,data) and that there was slightly enhanced IFNg produc-
tion in Th1 cell cultures from IL-132/2 mice (Figure 2A). pathways including mast cell± and eosinophil-derived
IL-4 may result in the development of IL-13-independentThis indirect role for IL-13 in regulating macrophage
function and thereby modulating T cell development T cell subsets.
Athough there is no precedent for the existence of amay also explain why addition of IL-13 to in vitro cultures
failed to reverse the observed phenotype and why by locus control region for the IL-13/IL-4/IL-5 gene cluster,
it was formally possible that the promoter driving thecontrast in vivo treatment of animals with IL-13 was able
to influence Th2-like cytokine production (Figures 6A neor gene had affected the transcription of these cyto-
kine genes. We felt this explanation was unlikely due toand 6B).
However, an alternative explanation involving a direct the cellular specificity of the phenotype with the precise
retention of transcriptional control in mast cells, the un-effect of IL-13 on T cells cannot be ruled out. Observa-
tions from thehuman system have indicated that primary affected IL-4-driven IgE response to N. brasiliensis, the
lack of effect on the closely linked (z40 kb) interferonhuman T cells can respond both functionally to IL-13
(Jinquan et al., 1995) and by phosphorylating Stat6 (Cu- response factor gene (IRF1) (data not shown), and be-
cause insertion of the neor gene into the IL-4 gene (KuÈ hnriel et al., 1997). In addition, it has been shown that
upon activation human T cells down-regulate IL-13Ra1 et al., 1991; Kopf et al., 1993) or the IL-5 gene (Kopf et
al., 1996) does not mimic the phenotype seen in the IL-expression (Gauchat et al., 1997), presumably with an
attendant loss of IL-13 responsiveness. Thus, isolated 13-deficient mice. However, to rule out the possibility
of promoter interference, we used cre-loxP recombina-mouse T cells may become insensitive to IL-13 signals
in vitro due to down-regulation of receptor subunits, tion to remove the PGK promoter/neor gene cassette
from the targeted IL-13 locus. Significantly, Th2 cytokinepossibly in a manner similar to that described for the
IFNg receptor on Th1 cells (Pernis et al., 1995). Certainly, production remained impaired even after the removal
of this element, supporting the hypothesis that thethe observed impairment of cellular commitment is not
simply due to a deficiency in cell surface expression of observed phenotype results from an absence of re-
sponding cells and not from an indirect transcriptionalIL-4Ra receptor, as identical levels were detected on T
cells from wild-type and IL-132/2 mice (data not shown). defect.
The IL-132/2 mice display significantly reduced levelsHowever, IL-13 may be involved in the expression or
activation of components of the IL-4/IL-13 signaling of IgE and CD23, and this may be directly attributable
to the lack of IL-13 or may also be explained by a failurepathway such as IRS-2, Jak1, Jak3, or Stat6. It is clear
that IL-13 and IL-4 share at least a subset of intracellular of the IL-13-deficient T cells to provide sufficient helper
functions to generate a robust IgE response. While it issignaling pathways, including the localization of Stat6
to the nucleus (Lin et al., 1995), and recent studies using clear that IL-42/2 mice have profoundly reduced IgE
levels (KuÈ hn et al., 1991; Kopf et al., 1993) and lowerStat62/2 mice have identified a severe Th2 block (Shi-
moda et al., 1996; Takeda et al., 1996) possibly due CD23 expression (HjulstroÈ m et al., 1995), the attendant
reduction in Th2 cytokines including IL-13 may contrib-to the combined effect of interrupting the downstream
signaling pathways of both IL-4 and IL-13 (Kaplan et al., ute to this phenotype. Interestingly, recent studies have
shown that IL-42/2 mice can still switch to IgE secretion1996). The presence of Stat6 binding sites in the IL-4
promoter (Lederer et al., 1996) and IL-4Ra promoter after infection with Plasmodium chabaudi (Van der Weld
et al., 1994) or during the course of a murine acquired(Kotanides and Reich, 1996) presents the possibility that
IL-13-induced Stat6 could play a role in modulating IL-4 immunodeficiency syndrome (Morawetz et al., 1996),
thus indicating an IL-4-independent mechanism for theand IL-4Ra expression, thereby influencing T cell expan-
sion. If this were the case, IL-13 produced by naive T production of IgE. Furthermore, recent data generated
in our laboratory have identified IL-13-specific, IL-4-cells (van der Pouw Kraan et al., 1996) may represent
an early source of cytokine for eliciting T cell function, independent, IgE regulation in mice transgenic for IL-
13 expression (Emson et al., 1998). Unlike IL-42/2 mice,including the induction of the IL-4 responsible for pro-
moting Th2 cell development. which display impaired IgG1 responses (KuÈ hn et al.,
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Ovalbumin Immunization1991; Kopf et al., 1993), these were normal in the IL-
Mice (8- to 10-week-old) were immunized in the peritoneal cavity132/2 animals. However, there were enhanced levels of
with 100 mg of ovalbumin adsorbed to aluminium hydroxide (alum)antigen-specific IgG2a and IgG2b produced by the IL-
with subsequent boost injections with 100 mg of ovalbumin after 7
132/2 animals, indicative of a more biased Th1 type and 14 days. Alternatively, 8- to 10-week-old mice were immunized
phenotype, correlating with slightly enhanced IFNg ex- intraperitoneally with 100 mg of ovalbumin/alum with subsequent
boost injections with 100 mg of ovalbumin/alum after 10, 20, and 30pression.
days. Serum samples were assayed for immunoglobulin isotypes.Kopf et al. (1993) suggested that IL-4-independent
Th subsets may be responsible for the residual Th2
ELISA Assayscytokines detected in IL-42/2 animals, proposing that
Serum immunoglobulins were assayed using sandwich ELISA. 96-
Thp or Th0 T cellsmay be IL-4-independentwhile chroni- well plates were coated with monoclonal anti-immunoglobulin iso-
cally stimulated Th cells are IL-4-dependent. Thus, our type capture antibodies, and bound immunoglobulin of diluted
results may go some way to explaining the capacity for serum samples was detected using biotinylated monoclonal anti-
immunoglobulin isotype detection antibodies (Pharmingen). Con-IL-4-independent differentiation to a Th2 cell phenotype
centrations were calculated using purified immunoglobulin isotypesas reported by others (Brewer et al., 1996; Constant et
as standards (Pharmingen). Ovalbumin-specific ELISA were per-al., 1995; van der Pouw Kraan et al., 1996). It is evident
formed by coating 96-well plates with ovalbumin at 2.5 mg/ml; bound
that complex interrelated roles exist for IL-13 and IL-4 immunoglobulin of diluted serum samples was detected using bio-
in the development of immune reactions, and though tinylated monoclonal anti-immunoglobulin isotype detection anti-
initially thought redundant, these cytokines elicit spe- bodies (Pharmingen). Cytokine ELISA also utilized the sandwich
format with capture and detection antibodies purchased from Phar-cific responses (Bancroft et al., 1998; McKenzie et al.,
mingen. ELISA were performed according to Pharmingen ELISA1998; Urban et al., 1998). In light of our findings, the IL-
protocol. The IL-13 ELISA was purchased from R & D (Abingdon, UK).13-deficient mice will prove an important tool in clarify-
ing the relative roles of these closely related cytokines Preparation of CD41 T Cells
in the generation of immune responses in infectious Splenocytes were cultured on plastic tissue culture plates for 1 hr
diseases and allergy. at 378C to remove macrophages. Nonadherent cells were incubated
with biotinylated anti-I-Ab antibody (clone AF6-120.1, Pharmingen),
biotinylated anti-CD8 antibody (clone 53-6.7, Pharmingen), biotiny-Experimental Procedures
lated anti-B220 antibody (clone RA3-6B2, Pharmingen), and strep-
tavidin magnetic beads (MACS, Miltenyi Biotec, Bergisch Gladbach,Targeted Disruption of the IL-13 Gene
Germany) followed by magnetic field separation to remove MHCThree independently derived IL-13-deficient mouse lines have been
class II±, CD8-, and B220-expressing cells. Cell purity was deter-used in this study. IL-13KO was generated as follows. Genomic
mined using FITC-labeled anti-CD4 and PE-labeled anti-CD8 anti-DNA clones were isolated as detailed in McKenzie et al. (1993b).
bodies and was generally 90%±95% CD41 cells. Purified cells wereThe neomycin resistance gene was inserted into exon 3, with stop
cultured on anti-CD3e antibody-coated plates (10 mg/ml of clonecodons in all three frames 59 of the selectable marker. The vector
2C11, Pharmingen) plus anti-CD28 antibody (1 mg/ml of clone 37.51,was linearized with SalI and transfected into E14.1 ES cells by elec-
Pharmingen) in the presence of exogenous cytokines or anti-cyto-troporation. BglII-digested genomic DNAs from isolated clones were
kine antibody as indicated. IL-2 (10 ng/ml, R & D) was added to allscreened using a 39 flanking probe. The probe was made by PCR
cultures. Th2 cell differentiation was promoted in the presence ofusing the primers 59-AAGAGCCCGAGGCATGATGCG-39 and 59-TCT
100 ng/ml IL-4 (R & D) and anti-IFNg antibody (10 mg/ml of cloneGGGCGCTATTGCTTGGTCTCTTCTGCC-39. Subsequent hybridiza-
XMG1.2, Pharmingen), while Th1 differentiation was promoted bytion of Southern blots with a neor probe (probe B) confirmed the
anti-IL-4 antibody at 40 mg/ml (clone 11B11, DNAX Research Insti-predicted size of the targeted fragment and a single integration
tute) and IL-12 (1 ng/ml, Genzyme, West Malling, UK). Cells wereevent. IL-132/2 was generated as described in McKenzieet al. (1998).
cultured for 5 days, washed, and resuspended at 1 3 106 cells/mlIL-132/2 creed was generated essentially as outlined in McKenzie
for 24 hr in the presence of anti-CD3. Supernatants were analyzedet al. (1998), with the exception that the neomycin resistance gene
by cytokine ELISA performed as above.was excised using cre-mediated loxP recombination. A correctly
targeted ES cell clone was identified and transiently transfected
N. brasiliensis Infectionwith plasmid pPGKcrebpA encoding the cre recombinase gene (a
Individual mice were inoculated subcutaneously with 400 viablegift from Dr. Werner Muller, Cologne). BamHI-digested genomic
third-stage N. brasiliensis larvae.DNAs from isolated ES cell colonies were screened for cre-mediated
recombination using Southern analysis employing the mIL-13 cDNA
as a probe. Prospective clones were then replica-plated in the pres- Antigen-Specific T Cell Stimulation Using Soluble
ence and absence of G418, and drug-susceptible clones were sub- Schistosome Egg Antigen
cloned and rescreened using Southern analysis. ES cells containing Mice were immunized intraperitoneally with 10,000 nonviable Schis-
the correctly recombined targeting event were used to derive chime- tosomamansoni eggs(Pearce et al., 1991). After 10 days, mesenteric
ric mice that were crossed with C57BL/6 females to generate hetero- LN cells were prepared and cultured at 5 3 106 cells per ml in the
zygous IL-131/2 creed animals. These were interbred to generate presence of soluble egg antigen (SEA, 20 mg/ml) for 5 days (Pearce
homozygous IL-132/2 creed mice and wild-type littermates. With et al., 1991). Anti-IL-4Ra antibody (Genzyme) at 0.5 mg/ml was added
the exception of the mast cell data, which were only generated for the final 24 hr of culture. Supernatants were analyzed for cyto-
using the IL-13KO line, all presented experiments were reproduced kines using ELISA.
using the IL-132/2 line described in McKenzie et al. (1998).
Mast Cell Preparation and Stimulation
Bone marrow was aseptically flushed from femora and tibias ofRNA Preparation
Spleen cells were cultured with 2 mg/ml of Con A for 48 hr. Total 8-week-old mice. The cell suspension was cultured at 4 3 105
cells/ml in the presence of 5 ng/ml of IL-3 and 10% WEHI-3B condi-RNA was prepared using RNAzolB (Biotecx, Biogenesis, Poole, UK),
and polyA1 RNA was isolated with Oligotex (Qiagen, Dorking, UK). tioned supernatant for 3±4 weeks, with media changes every 7 days.
The resultant cell populations were 95% c-kit1 and Gr-11 whenRT-PCR primers for IL-13 were 59-GGGTGACTGCAGTCCTGGCT-39
and 59-GCTGGAGACCGTAGTGGG-39. The internal oligonucleotide analyzed by flow cytometry (Pharmingen). After washing, cells were
resuspended at 1 3 106 cells/ml and stimulated either for 4 hr forused for hybridization was 59-CTGTGCAACGGCAGCATGGTA-39.
HPRT primers and conditions were as described in Murphy et al. the analysis of cytokine mRNA production or24 hr for the determina-
tion of secreted cytokine. Cells were stimulated with the polyclonal(1993).
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activators PMA at 50 ng/ml and/or calcium ionophore A23187 at Brewer, J.M., Conacher, M., Satoskar, A., Bluethmann, H., and Alex-
ander, J. (1996). In interleukin-4-deficient mice, alum not only gener-500 ng/ml. IgE cross-linking was performed by first incubating the
cells for 30 min in the presence of 3 mg/ml of monoclonal mouse ates Thelper 1 responses equivalent to Freund's complete adjuvant,
but continues to induce T helper 2 cytokine production. Eur. J.IgE anti-DNP (clone SPE-7, from Sigma Chemical Co., Poole, UK),
before washing the cells and resuspending in the presence of 10 Immunol. 26, 2062±2066.
ng/ml of DNP30±40 human serum albumin (Sigma). Cytokine mRNA Brown, K.D., Zurawski, S.M., Mosmann, T.R., and Zurawski, G.
production was analyzed using reverse transcriptase (RT)-PCR us- (1989). A family of small inducible proteins secreted by leukocytes
ing the pPQRSplasmid andprimers describedby Reiner et al. (1993), are members of a new superfamily that includes leukocyte and
with the exception of IL-13 mRNA, which was detected with the fibroblast-derived inflammatory agents, growth factors, and indica-
primers outlined above. Cytokine secretion was assessed using tors of various activation processes. J. Immunol. 142, 679±687.
ELISA. Caput, D., Laurent, P., Kaghad, M., Lelias, J-M., Lefort, S., Vita, N.,
and Ferrara, P. (1996). Cloning and characterization of a specific
interleukin (IL)-13 binding protein structurally related to the IL-5Administration of Recombinant IL-13
receptor a chain. J. Biol. Chem. 271, 16921±16926.The mouse IL-13 cDNA sequence was inserted downstream of an
oligonucleotide encoding the FLAG epitope in the mammalian cell Constant, S., Pfeiffer, C., Pasqualini, T., and Bottomly, K. (1995).
expression vector pME18S (Zurawski et al., 1995) to form a fusion Extent of T cell receptor ligation can determine the functional differ-
protein with the FLAG epitope at the N terminus of the IL-13 protein. entiation of naive CD41 T cells. J. Exp. Med. 182, 1591±1596.
IL-13/FLAG was purified, from tissue culture supernatants collected Curiel, R.E., Lahesmaa, R., Subleski, J., Cippitelli, M., Kirken, R.A.,
from COS7 cells transfected with the IL-13/flag plasmid vector, us- Young, H.A., and Ghosh, P. (1997). Identification of a Stat-6-respon-
ing the M2 anti-FLAG monoclonal antibody affinity column (Kodak, sive element in the promoter of the human interleukin-4 gene. Eur.
New Haven, CT). IL-13 concentration was assessed by ELISA, and J. Immunol. 27, 1982±1987.
bio-activity was determined using the B9 cell line (Aarden et al.,
de Waal Malefyt, R., Figdor, C., Huijbens, R., Mohan-Peterson, S.,1987). SDS-PAGE analysis indicated that the protein was approxi-
Bennett, B., Culpepper, J., Dang, W., Zurawski, G., and de Vries,mately 80% pure. Mice were inoculated intraperitoneally with 10,000
J.E. (1993). Effects of IL-13 on phenotype, cytokine production, andnonviable S. mansoni eggs in the presence of either 2.5 mg of active
cytotoxic function of human monocytes. J. Immunol. 151, 6370±recombinant IL-13 or 2.5 mg of denatured IL-13 (boiled for 15 min).
6381.At 3 and 6 days, the animals were given additional 2.5 mg doses of
Doherty, T.M., Kastelein, R., Menon, S., Andrade, S., and Coffman,cytokine or denatured protein intraperitoneally. After 10 days, ani-
R.L. (1993). Modulation of murine macrophage function by interleu-mals were sacrificed and mesenteric LN cells were cultured for 5
kin-13. J. Immunol. 151, 7151±7160.days in the presence of 20 mg/ml of SEA as described above.
Alternatively, IL-132/2 mice were infected with N. brasiliensis and Emson, C.L., Bell, S.E., Jones, A., Wisden, W., and McKenzie, A.N.J.
(1998). IL-4-independent induction of IgE, and perturbation of T cellin addition were injected intraperitoneally with either PBS or PBS
development in transgenic mice expressing interleukin-13. J. Exp.containing 0.5 mg of rmIL-13 (R & D Systems). Repeat administra-
Med. 188, 399±404.tions of PBS or rmIL-13 (0.5 mg) were given intraperitoneally after
3 days, and the animals were sacrificed 6 days postinfection. Gauchat, J-F., Schlagenhauf, E., Feng, N-P., Moser, R., Yamage,
M., Jeannin, P., Alouani, S., Elson, G., Notarangelo, L.D., Wells, T.,
et al. (1997). A novel 4-kb interleukin-13 receptor a mRNA expressedAcknowledgments
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